ProShare Advisors
SPRY icon

ProShare Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

ProShare Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Sell
12,974
-2,165
-14% -$20.7K ﹤0.01% 1702
2025
Q4 		$176K Buy
15,139
+1,532
+11% +$14.9K ﹤0.01% 1757
2025
Q3 		$137K Sell
13,607
-1,303
-9% -$18.7K ﹤0.01% 1781
2025
Q2 		$260K Sell
14,910
-127
-0.8% -$1.83K ﹤0.01% 1547
2025
Q1 		$189K Sell
15,037
-3,426
-19% -$41.2K ﹤0.01% 1707
2024
Q4 		$195K Buy
18,463
+3,436
+23% +$48.1K ﹤0.01% 1895
2024
Q3 		$218K Buy
+15,027
New +$179K ﹤0.01% 1675
2024
Q2 		– Sell
-11,139
Closed -$114K – 1993
2024
Q1 		$114K Buy
11,139
+942
+9% +$7.02K ﹤0.01% 1798
2023
Q4 		$55.9K Buy
+10,197
New +$44.7K ﹤0.01% 1847

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return